Biochemical risk markers and 10‐year incidence of atherosclerotic cardiovascular disease: independent predictors, improvement in pooled cohort equation, and risk reclassification

No abstract is available for this paper.

• Publication year

  2017

• Venue

  American Heart Journal

• Publication date

  2017-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ahj.2017.08.002PMID 29129262
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Soluble ST2 predicts 1‐year outcome in patients undergoing transcatheter aortic valve implantation

  2017cited by this paper
• Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment

  2017cited by this paper
• Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death

  2017cited by this paper
• Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction.

  2017cited by this paper
• Preventing Atherosclerotic Cardiovascular Disease Using American College of Cardiology and American Heart Association Prevention Guidelines: Some Good News, But Caveats Remain

  2016cited by this paper
• Albuminuria: the kidney message on cardiovascular health.

  2016cited by this paper
• Utility of Nontraditional Risk Markers in Atherosclerotic Cardiovascular Disease Risk Assessment.

  2016cited by this paper
• Role of Coronary Artery Calcium Score of Zero and Other Negative Risk Markers for Cardiovascular Disease: The Multi-Ethnic Study of Atherosclerosis (MESA)

  2016cited by this paper
• Albuminuria: the kidney message on cardiovascular health

  2016cited by this paper
• An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort.

  2015cited by this paper
• Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).

  2015cited by this paper
• Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines

  2015cited by this paper
• 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2014cited by this paper
• 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2014cited by this paper
• Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.

  2014cited by this paper
• 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cited by this paper
• Statins: new American guidelines for prevention of cardiovascular disease.

  2013cited by this paper
• New directions in cardiovascular risk assessment: the role of secondary risk stratification markers

  2012cited by this paper
• Interleukin-6 receptor pathways in coronary heart disease : a collaborative meta-analysis of 82 studies

  2012cited by this paper
• Homocysteine and reclassification of cardiovascular disease risk.

  2011cited by this paper
• Contribution of 30 Biomarkers to 10-Year Cardiovascular Risk Estimation in 2 Population Cohorts: The MONICA, Risk, Genetics, Archiving, and Monograph (MORGAM) Biomarker Project

  2010cited by this paper
• Emerging Risk Factors for Coronary Heart Disease: A Summary of Systematic Reviews Conducted for the U.S. Preventive Services Task Force

  2009cited by this paper
• Novel and conventional biomarkers for prediction of incident cardiovascular events in the community.

  2009cited by this paper
• Coronary calcium as a predictor of coronary events in four racial or ethnic groups.

  2008cited by this paper
• Updating methods improved the performance of a clinical prediction model in new patients.

  2008cited by this paper
• The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve.

  2006cited by this paper
• Multi-Ethnic Study of Atherosclerosis: objectives and design.

  2002cited by this paper
• Index for rating diagnostic tests

  1950cited by this paper

• Relationship between dynamic changes in remnant cholesterol and cardiovascular disease in middle-aged and older Chinese: a national cohort study

  2025cites this paper
• Immune-related biochemical markers and 20-year incidence of atherosclerotic cardiovascular disease: the ATTICA study (2002-2022).

  2025cites this paper
• Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease

  2024cites this paper
• Development and Validation of the CANHEART Population-Based Laboratory Prediction Models for Atherosclerotic Cardiovascular Disease

  2023cites this paper
• Cardiovascular Disease and Alzheimer's Disease: The Heart–Brain Axis

  2023cites this paper
• Machine learning derived ECG risk score improves cardiovascular risk assessment in conjunction with coronary artery calcium scoring

  2022cites this paper
• High sensitivity troponin, analytical advantages, clinical benefits and clinical challenges - an update.

  2021cites this paper
• Advancements in biomarkers for cardiovascular disease: diagnosis, prognosis, and therapy

  2021cites this paper
• Prognostic Utility of Risk Enhancers and Coronary Artery Calcium Score Recommended in the 2018 ACC/AHA Multisociety Cholesterol Treatment Guidelines Over the Pooled Cohort Equation: Insights From 3 Large Prospective Cohorts

  2021cites this paper
• Cardiovascular risk and aging: the need for a more comprehensive understanding

  2021cites this paper
• The 2013 ACC/AHA risk score and subclinical cardiac remodeling and dysfunction: Complementary in cardiovascular disease prediction.

  2019cites this paper
• Clinician's Guide to the Updated ABCs of Cardiovascular Disease Prevention: A Review Part 1.

  2019cites this paper
• Patient-Centered Risk Assessment in Implant Treatment Planning.

  2019cites this paper
• Future Directions in the Use of Biomarkers for Prevention of Cardiovascular Disease

  2019cites this paper
• The Use of Biomarkers in Clinical Management Guidelines: A Critical Appraisal

  2019cites this paper
• Performance of atherosclerotic cardiovascular risk prediction models in a rural Northern Chinese population: Results from the Fangshan Cohort Study

  2019cites this paper
• Cardiovascular risk prediction in older adults with the use of biomarkers.

  2018cites this paper
• Novel biomarkers of cardiovascular disease: Applications in clinical practice

  2018cites this paper
• Low-grade inflammation in first-episode psychosis is determined by increased waist circumference.

  2018cites this paper
• Toward a panoramic perspective of the association between environmental factors and cardiovascular disease: An environment-wide association study from National Health and Nutrition Examination Survey 1999-2014.

  2018cites this paper